Crossmark

Biological sequential therapy with rituximab-belimumab in patients with recurrent lupus nephritis

Crossref DOI link: https://doi.org/10.1016/j.reumae.2022.03.001

Published Print: 2023-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Robles-Marhuenda, Angel

Cobo-Ibáñez, Tatiana

Noblejas-Mozo, Ana

Muñóz-Fernández, Santiago
License Information

Text and Data Mining valid from 2023-05-01
More Information

This article is maintained by: Elsevier

Article Title: Biological sequential therapy with rituximab-belimumab in patients with recurrent lupus nephritis

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2022.03.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2022.03.001

Content Type: simple-article

Copyright: © 2022 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.